Robert S. Ellin

Robert S. Ellin, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in LiveOne, Inc., Ernexa Therapeutics Inc. and PodcastOne, Inc. Over a trading history stretching from 26 September 2019 to 15 July 2025, the count stands at 109 filings.

In open-market terms, that means 97 purchases worth €986k on one side and 6 sales worth €1.6M on the other. Sales outweigh purchases by €620k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant.

Half of the purchases are above €6,884 and half below. Clusters matter here: 57 out of 83 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 32 purchases show a median change of -15.0%, with the price up in 41% of them. These figures describe past trades and do not predict future prices.

Most recently, on 17 July 2025, the filings show a transaction worth €1.9M in LiveOne, Inc. The most recent open-market purchase was published on 2 December 2024, 691 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.